José Valentín
García Gutiérrez

Profesor/a Asociado/a en CC. de la Salud

Foto de José Valentín

Foto de Carmen

Carmen
Burgaleta Alonso de Ozalla

Publicacións nas que colabora con Carmen Burgaleta Alonso de Ozalla (6)

2017

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase
PLoS ONE, Vol. 12, Núm. 7
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea
Haematologica, Vol. 102, Núm. 1, pp. 103-109

2016

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation
Haematologica, Vol. 101, Núm. 8, pp. 926-931
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera
British Journal of Haematology, Vol. 172, Núm. 5, pp. 786-793

2015

Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months
Cancer Medicine, Vol. 4, Núm. 7, pp. 995-1002

2014

Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor?
American Journal of Hematology, Vol. 89, Núm. 11, pp. E206-E211